The Impact of the Distribution of Adipose Tissue on the Occurrence of Metabolic Disorders and the Level of Cardiopulmonary Fitness

NCT05612282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2022-11-10

No results posted yet for this study

Summary

The aim of the research was to assess the impact of the distribution of abdominal fat (subcutaneous SAT and visceral VAT estimated at the height of the navel) on selected metabolic parameters and on specific parameters of cardiopulmonary fitness in terms of people with obesity.

Conditions

  • Obesity, Abdominal

Interventions

DIAGNOSTIC_TEST

body composition analysis

A body composition analysis was performed using the bioelectroimpedance method using the Maltron BioScan 920-2 analyzer

OTHER

anthropometric measurements

An assessment of the status of nutrition based on anthropometric measurements was carried out.

OTHER

Interview questionnaire

An interview questionnaire concerning the duration of obesity and past diseases was collected. Moreover, the diet and nutritional status were assessed.

DIAGNOSTIC_TEST

biochemical parameters

The concentrations of the following parameters were determined from the blood serum: fasting glucose, fasting insulin, total cholesterol, LDL cholesterol fraction, HDL cholesterol fraction, triglycerides, C-reactive protein (CRP), uric acid, creatinine, and aminotrasferases: alanine (ALT) and aspartate (AST). On the basis of fasting glucose and fasting insulin, the HOMA - IR insulin resistance index was calculated.

DIAGNOSTIC_TEST

cardiopulmonary fitness test

Cardiopulmonary fitness was assessed using the Modified Bruce protocol

OTHER

nutritional interview

A 7-day nutrition interview was collected. The supply of energy, protein (including amino acids), fat (including fatty acids), carbohydrates, dietary fiber, vitamins and minerals in the usual diet was assessed.

Sponsors & Collaborators

  • Medical University of Bialystok

    lead OTHER

Principal Investigators

  • Katarzyna Witczak - Sawczuk, PhD · Medical University of Bialystok

  • Lucyna Ostrowska, Professor · Medical University of Bialystok

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-11
Primary Completion
2017-10-31
Completion
2017-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05612282 on ClinicalTrials.gov